METHOD FOR ASCERTAINING AT LEAST ONE PHYSICAL PARAMETER OF A SYSTEM BY EXPLOITING THE REFLECTION FROM A REFERENCE OBJECT

    公开(公告)号:US20210041550A1

    公开(公告)日:2021-02-11

    申请号:US16978326

    申请日:2019-03-05

    Abstract: A method for determining at least one physical parameter of a system comprising at least two reflection objects is presented, comprising: producing a transmission signal comprising at least one modulated electromagnetic or acoustic wave; receiving a first reception signal that is based on the transmission signal reflected by a first reflection object; receiving a second reception signal that is based on the transmission signal reflected by a second reflection object; receiving a third or further reception signal(s) that is/are based on the transmission signal reflected by a first or second or further reflection object(s); ascertaining the at least one physical parameter of the system on the basis of the first reception signal and further reception signals; ascertaining unknown distances between reflection objects or material properties, composition or nature of the media between the reflection objects of the system on the basis of the first reception signal and further reception signals.

    HETERODIMERIZING IG DOMAINS
    32.
    发明申请

    公开(公告)号:US20200172619A1

    公开(公告)日:2020-06-04

    申请号:US16615536

    申请日:2018-06-01

    Abstract: The present invention provides a protein complex comprising heterodimerizing regions HRI and HRII, each comprised of antiparallel β-strands and intervening regions wherein HRI and HRII are each interspersed fusion proteins of two human constant regions of an immunoglobulin or immunoglobulin-like proteins. The present invention also provides nucleic acid molecules comprising a sequence encoding said protein complexes and vectors comprising the nucleic acid. The present invention also provides the protein complex, the nucleic acid and the vector for use as a medicament. The present invention further provides a method of determining the amino acid sequence of HRI and/or of the amino acid sequence of HRII. The present invention also provides a method of producing amino acid chains of HRI and/or amino acid chains of HRII. The present invention further provides the protein complex for use in the N prophylaxis, treatment or diagnosis of a disorder or a disease.

    BACTERIAL STRAIN AND METHOD FOR HIGH THROUGHPUT OF SUGAR IN THE MICROBIAL CONVERSION INTO BIOSYNTHETIC PRODUCTS

    公开(公告)号:US20190144815A1

    公开(公告)日:2019-05-16

    申请号:US16093479

    申请日:2017-03-22

    Abstract: The present invention relates to recombinant Escherichia coli (E. coli) host cells comprising, in relation to wild-type cells, at least one mutation selected from the group consisting of deletion of the gene relA (ΔrelA); amino acid substitutions R290E and K292D in the protein guanosine-3′,5′-bis pyrophosphate 3′-pyrophosphohydrolase (bifunctional (p)ppGpp synthetase II; SpoT) (spo T[R290E;K292D]); and amino acid substitution G267C in the protein pyruvate dehydrogenase subunit E1 (AceE) (aceE[G267C]). Said recombinant host cells are characterized by increased sugar uptake rates that lead to increased productivity when using said cells for the production of biosynthetic products. The present invention further relates to respective methods for the biosynthetic production of a product of interest using said host cells.

    SINGLE-CHAIN TNF LIGAND FAMILY MOLECULES AND FUSION PROTEINS AND DERIVATIVES THEREOF

    公开(公告)号:US20180094059A1

    公开(公告)日:2018-04-05

    申请号:US15558372

    申请日:2016-03-18

    Abstract: The present invention relates to a polypeptide comprising a component A with at least three tumor necrosis factor (TNF) homology domains of TNF-ligand family members (THD) in which C-terminal and N-terminal reference points are defined by consensus sequences and which are connected through short stretches of additional C-terminal and/or N-terminal amino acids of the THD or variants thereof, and a component B comprising a dimerization domain. Further, the present invention relates to a polypeptide comprising at least three THDs in which C-terminal and N-terminal reference points are defined by consensus sequences and which are connected through short stretches of additional C-terminal and/or N-terminal amino acids of the THD or variants thereof. Further, the invention relates to a nucleic acid comprising said polypeptides, a vector comprising said nucleic acid and a pharmaceutical composition comprising said polypeptides, or said nucleic acids or said vector. Further, the present invention relates to said polypeptides, said nucleic acid or said vector for the use as a medicament or for the use in the diagnosis, prophylaxis or treatment of hyperproliferative disorders and inflammatory disorders.

    N-Heterocyclic Carbene Complexes Of Metal Imido Alkylidenes And Metal OXO Alkylidenes, And The Use Of Same
    39.
    发明申请
    N-Heterocyclic Carbene Complexes Of Metal Imido Alkylidenes And Metal OXO Alkylidenes, And The Use Of Same 审中-公开
    金属亚氨基亚烷基和金属OXO亚烷基的N-杂环辛烯配合物及其用途

    公开(公告)号:US20170050994A1

    公开(公告)日:2017-02-23

    申请号:US15306521

    申请日:2015-04-24

    Abstract: The invention relates to an N-heterocyclic carbene complex of general formulas I to IV (I) (II) (III) (IV), according to which A1 stands for NR2 or PR2, A2 stands for CR2 R2′, NR2, PR2, 0 or S, A3 stands for N or P, and C stands for a carbene carbon atom, ring B is an unsubstituted or a mono or poly-substituted 5 to 7-membered ring, substituents R2 and R2′ stand, inter alia, for a linear or branched C1-Cw-alkyl group and, if N and N each stand for NR2 or PR2, are the same or different, M in formulas I, II, III or IV stands for Cr, Mo or W, X 1 or X2 in formulas I to IV are the same or different and represent, inter alia, C1-C1s carboxylates and C1-C1s-alkoxides, Y is inter alia oxygen or sulphur, Z is inter alia a linear or branched C1-Cw-alkylenoxy group, and R 1 and R1′ in formulas I to IV are, inter alia, an aliphatic or aromatic group. These compounds are particularly suitable for use as catalysts for olefin metathesis reactions and have the advantage, compared to known Schrock carbene complexes, of displaying clearly increased tolerance to functional groups such as, in particular, aldehydes, secondary amines, nitriles, carboxylic acids and alcohols.

    Abstract translation: 本发明涉及通式I至IV(I)(II)(III)(IV)的N-杂环卡宾络合物,其中A1代表NR2或PR2,A2代表CR2 R2',NR2,PR2, 0或S,A3代表N或P,C代表碳原子,环B是未取代的或单取代的或多取代的5至7元环,取代基R 2和R 2'尤其用于 直链或支链C 1 -C 6烷基,如果N和N各自代表NR 2或PR 2,则相同或不同,式I,II,III或IV中的M代表Cr,Mo或W,X 1或 式I至IV中的X 2相同或不同,特别表示C 1 -C 6羧酸酯和C 1 -C 6醇盐,Y尤其是氧或硫,Z尤其是直链或支链C 1 -C 6 - 亚烷基氧基 ,式I至IV中的R 1和R 1'特别是脂族或芳族基团。 这些化合物特别适合用作烯烃复分解反应的催化剂,并且与已知的Schrock卡宾络合物相比具有明显增加的对官能团的耐受性,特别是醛,仲胺,腈,羧酸和醇的显着增加的优点 。

Patent Agency Ranking